Ticker,Title,Link
CNTX,Buy Rating Affirmed for Context Therapeutics Amid Strong Financials and Promising CLDN6-Targeting Therapies,8/9/2024 4:05:59 PM
CNTX,Context Therapeutics GAAP EPS of -$0.04,8/8/2024 2:27:05 PM
CNTX,Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results,8/7/2024 10:17:13 PM
CNTX,Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations,8/1/2024 1:30:00 PM
CNTX,Buy Rating Justified by Context Therapeutics’ Strategic Acquisition and Promising T Cell Engager Pipeline,7/11/2024 5:25:17 PM
CNTX,Strategic Acquisition and Innovative T Cell Engager Development Secure Buy Rating for Context Therapeutics,7/10/2024 4:25:33 PM
CNTX,Hypergrowth Hits: 3 Stocks Clocking Triple-Digit Gains with No End in Sight ,5/30/2024 10:11:00 AM
CNTX,The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains,5/23/2024 12:50:47 AM
CNTX,Optimistic Outlook for Context Therapeutics’ CTIM-76 Based on Targeting Efficacy and Market Potential,5/16/2024 7:55:38 AM
CNTX,Context Therapeutics GAAP EPS of -$0.23,5/9/2024 3:36:23 PM
CNTX,Context Therapeutics Reports First Quarter 2024 Operating and Financial Results,5/8/2024 10:06:26 PM
CNTX,"AEON, SGBX and APVO among pre-market losers",5/3/2024 12:36:49 PM
CNTX,"CytomX Therapeutics, Allarity Therapeutics, Pulmonx among healthcare movers",5/2/2024 2:00:43 PM
CNTX,Buy Rating on Context Therapeutics’s CTIM-76 Bolstered by Market Validation and Competitive Edge,4/11/2024 5:15:32 PM
CNTX,Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers,4/1/2024 1:30:00 PM
CNTX,Buy Rating Justified by Advances in T Cell Engagers and Context Therapeutics’ Strategic Drug Positioning,3/22/2024 5:55:15 PM
CNTX,CNTX Stock Earnings: Context Therapeutics Misses EPS for Q4 2023,3/21/2024 5:53:01 PM
CNTX,Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session,12/15/2023 6:46:25 PM
CNTX,Context Therapeutics’ Promising Financial and Preclinical Results Bolster Buy Rating: A Focus on CTIM-76’s High Potency and Target Specificity,11/11/2023 12:06:20 PM
CNTX,Promising Potential of CTIM-76 Drug: A Comprehensive Buy Rating Analysis for Context Therapeutics,11/10/2023 11:47:45 AM
CNTX,Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results,11/9/2023 10:15:51 PM
CNTX,Wall Street Analysts Are Bullish on Top Healthcare Picks,11/1/2023 10:20:35 AM
CNTX,Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76,10/31/2023 2:00:00 PM
CNTX,"Analysts Are Bullish on These Healthcare Stocks: AstraZeneca (AZN), Context Therapeutics (CNTX)",10/24/2023 7:10:32 PM
CNTX,Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket,10/2/2023 2:11:58 PM
CNTX,Context Therapeutics’ Promising CLDN6 Targeting Asset CTIM-76 and Potential Market Valuation Opportunities: An Analyst’s Buy Rating Perspective,9/28/2023 6:26:08 PM
CNTX,Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting,9/27/2023 3:00:00 PM
CNTX,"Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023",9/11/2023 5:00:28 PM
CNTX,Context Therapeutics GAAP EPS of -$0.31,8/10/2023 6:26:07 PM
CNTX,"Sientra, ContraFect top healthcare gainers; Elevation, Longboard among losers",6/9/2023 2:07:38 PM
CNTX,"Aclarion, Bone Biologics top healthcare gainers; Panbela, Akoya among losers",6/8/2023 2:04:22 PM
CNTX,Context Therapeutics (CNTX) Gets a Hold from H.C. Wainwright,6/6/2023 10:25:18 AM
CNTX,Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session,6/5/2023 7:09:09 PM
CNTX,Context Therapeutics (CNTX) Gets a Hold from H.C. Wainwright,5/11/2023 10:25:27 AM
CNTX,Context Therapeutics GAAP EPS of -$0.40 misses by $0.21,5/10/2023 9:30:51 PM
CNTX,H.C. Wainwright Remains a Hold on Context Therapeutics (CNTX),4/18/2023 10:25:23 AM
CNTX,"Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023",3/23/2023 4:00:55 PM
CNTX,Context Therapeutics GAAP EPS of -$0.93,3/22/2023 9:22:56 PM
CNTX,Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Context Therapeutics (CNTX),2/7/2023 11:20:15 AM
CNTX,Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket,2/1/2023 1:55:16 PM
CNTX,Dow Surges Over 200 Points; Pfizer Issues Weak Forecast,1/31/2023 8:37:20 PM
CNTX,Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session,12/8/2022 6:56:24 PM
CNTX,EQS-News: Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers,12/6/2022 12:40:05 PM
CNTX,Context Therapeutics (CNTX) Receives a Buy from H.C. Wainwright,12/2/2022 11:15:31 AM
CNTX,Context Therapeutics® Announces Clinical Updates on ONA-XR to be Presented at 2022 San Antonio Breast Cancer Symposium,11/21/2022 3:11:50 PM
CNTX,H.C. Wainwright Remains a Buy on Context Therapeutics (CNTX),11/10/2022 11:17:25 AM
CNTX,Context Therapeutics GAAP EPS of -$0.24 beats by $0.01,11/9/2022 10:36:47 PM
CNTX,YMAB and FDMT among mid-day movers,10/27/2022 5:14:25 PM
CNTX,H.C. Wainwright Sticks to Their Buy Rating for Context Therapeutics (CNTX),9/27/2022 3:55:06 PM
CNTX,Context Therapeutics® to Participate in the H.C. Wainwright 24th Annual Global Investment Conference,9/6/2022 1:30:00 PM
CNTX,Context Therapeutics® Reports Second Quarter 2022 Operating and Financial Results,8/11/2022 10:01:00 PM
CNTX,"Quoin, Context top healthcare gainers; Ontrak, Phathom lead losers' pack",8/2/2022 2:03:45 PM
CNTX,"APRN, TSP and NCTY among pre market gainers",6/24/2022 12:34:26 PM
CNTX,"MCRB, MRTX and CNTX among pre market gainers",6/7/2022 12:39:37 PM
CNTX,"Gevo, Bright Green, Red Robin Gourmet Burgers among premarket losers' pack",6/6/2022 12:18:38 PM
CNTX,40 Stocks Moving In Friday's Mid-Day Session,6/3/2022 6:07:35 PM
CNTX,66 Biggest Movers From Friday,5/23/2022 9:57:58 AM
CNTX,Context Therapeutics® Reports First Quarter 2022 Operating and Financial Results,5/11/2022 10:01:00 PM
CNTX,Context Therapeutics® Announces Poster Presentation at the Upcoming 2022 ASCO Annual Meeting,5/5/2022 1:30:00 PM
CNTX,Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 ,4/11/2022 1:30:00 PM
CNTX,Context Therapeutics® to Participate in Two April 2022 Investor Conferences,4/6/2022 1:30:00 PM
CNTX,68 Biggest Movers From Yesterday,4/5/2022 12:37:16 PM
CNTX,35 Stocks Moving In Monday's Mid-Day Session,4/4/2022 6:12:22 PM
CNTX,Context Therapeutics® Reports Full Year 2021 Operating and Financial Results,3/23/2022 9:01:00 PM
CNTX,Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022,3/9/2022 12:12:06 AM
CNTX,Edison Investment Research Limited: Context Therapeutics (CNTX) - Initiation: Women's oncology play with a novel pipeline,2/25/2022 1:00:04 AM
CNTX,Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum,2/22/2022 1:30:00 PM
CNTX,"Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022",2/2/2022 4:05:51 PM
CNTX,Context Therapeutics® Strengthens Research & Development Team,1/5/2022 10:01:00 PM
CNTX,Context Therapeutics® to Participate in Two January 2022 Investor Conferences,1/4/2022 1:30:00 PM
CNTX,45 Biggest Movers From Yesterday,12/29/2021 10:06:03 AM
CNTX,25 Stocks Moving In Tuesday's Mid-Day Session,12/28/2021 6:06:58 PM
CNTX,32 Stocks Moving In Wednesday's Mid-Day Session,12/22/2021 6:03:37 PM
CNTX,59 Biggest Movers From Yesterday,12/14/2021 11:15:51 AM
CNTX,40 Stocks Moving In Monday's Mid-Day Session,12/13/2021 7:08:16 PM
CNTX,36 Stocks Moving In Friday's Mid-Day Session,12/10/2021 7:06:10 PM
CNTX,52 Biggest Movers From Yesterday,12/9/2021 9:07:46 AM
CNTX,35 Stocks Moving In Wednesday's Mid-Day Session,12/8/2021 6:00:41 PM
CNTX,Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement,12/6/2021 10:45:00 PM
CNTX,61 Biggest Movers From Yesterday,12/3/2021 11:11:37 AM
CNTX,Context Therapeutics® Reports Third Quarter 2021 Operating and Financial Results,12/2/2021 10:01:00 PM
CNTX,50 Stocks Moving In Wednesday's Mid-Day Session,12/1/2021 6:36:00 PM
CNTX,35 Stocks Moving In Tuesday's Mid-Day Session,11/30/2021 6:02:47 PM
CNTX,52 Biggest Movers From Friday,11/22/2021 10:53:11 AM
CNTX,33 Stocks Moving In Friday's Mid-Day Session,11/19/2021 6:00:35 PM
CNTX,"The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More",11/14/2021 3:57:21 PM
CNTX,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",11/2/2021 12:52:53 PM
CNTX,Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer,11/1/2021 9:02:00 PM
CNTX,64 Biggest Movers From Yesterday,10/28/2021 10:50:09 AM
CNTX,44 Stocks Moving In Wednesday's Mid-Day Session,10/27/2021 6:00:24 PM
CNTX,25 Stocks Moving in Tuesday's Pre-Market Session,10/26/2021 1:07:46 PM
CNTX,55 Biggest Movers From Friday,10/25/2021 11:28:32 AM
CNTX,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",10/24/2021 5:45:47 PM
CNTX,"Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option",10/22/2021 10:05:00 PM
CNTX,Context Therapeutics® Announces Pricing of Initial Public Offering,10/20/2021 1:14:15 AM
